Published on 10/25/2016 in the Prospect News Structured Products Daily.
New Issue: JPMorgan prices $1.6 million review notes linked to biotech ETF, S&P
By Angela McDaniels
Tacoma, Wash., Oct. 25 – JPMorgan Chase Financial Co. LLC priced $1.6 million of 0% review notes due Oct. 26, 2020 linked to the lesser performing of the S&P 500 index and the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
The notes will be called at par plus a premium of 16.5% per year if each underlier closes at or above its initial level on any annual review date.
If the notes are not called and the final level of each underlier is greater than or equal to its trigger value, 50% of its initial level, the payout at maturity will be par. Otherwise, investors will lose 1% for each 1% that the lesser-performing underlier's final level is less than its initial level.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Review notes
|
| Underliers: | S&P 500 index and SPDR S&P Biotech ETF
|
| Amount: | $1,597,000
|
| Maturity: | Oct. 26, 2020
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If notes are not called and each underlier finishes at or above trigger level, par; otherwise, 1% loss for each 1% that lesser-performing underlier’s final level is less than initial level
|
| Call: | Automatically at par plus 16.5% per year if each underlier closes at or above initial level on Oct. 30, 2017, Oct. 22, 2018, Oct. 21, 2019 or Oct. 21, 2020
|
| Initial levels: | 2,141.16 for index and $59.73 for ETF
|
| Trigger values: | 1,070.58 for index and $29.865 for ETF; 50% of initial levels
|
| Pricing date: | Oct. 21
|
| Settlement date: | Oct. 28
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 2.4%
|
| Cusip: | 46646E2D3
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
